Trial intelligence / Profile preview

Levocetirizine and hydroxyzine effects during simulated diving in professional navy divers

NL-OMON34370Phase 4Active, not recruiting

Sponsor
Utrecht University
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of levocetirizine and hydroxyzine in allergic rhinitis (AR) (3 arms), sponsored by Utrecht University. Primary endpoint: Percentage of errors on cognitive and psychomotor tests. Started Apr 2012; status: active, not recruiting.

02

Drugs

levocetirizinehydroxyzine
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on NL-OMON34370.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34370.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call